September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Long-term safety evaluation of suprachoroidal space following multiple suprachoroidal injection of triamcinolone acetonide (TA)
Author Affiliations & Notes
  • Mei Chen
    Institute of Ocular Pharmacology, School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou, Zhejiang, China
  • Shiyu Zhou
    Institute of Ocular Pharmacology, School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou, Zhejiang, China
  • Ping Lu
    Institute of Ocular Pharmacology, School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou, Zhejiang, China
  • Qingkai Ma
    Institute of Ocular Pharmacology, School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou, Zhejiang, China
  • Akram Belghith
    Department of Ophthalmology, University of California San Diego, Jacob’s Retina Center at Shiley Eye Institute, San Diego, California, United States
  • Lingyun Cheng
    Institute of Ocular Pharmacology, School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou, Zhejiang, China
    Department of Ophthalmology, University of California San Diego, Jacob’s Retina Center at Shiley Eye Institute, San Diego, California, United States
  • Footnotes
    Commercial Relationships   Mei Chen, None; Shiyu Zhou, None; Ping Lu, None; Qingkai Ma, None; Akram Belghith, None; Lingyun Cheng, None
  • Footnotes
    Support  National Natural Science Foundation of China, Grant No.31271022, NIH P30 core grant P30EY022589
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 762. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Mei Chen, Shiyu Zhou, Ping Lu, Qingkai Ma, Akram Belghith, Lingyun Cheng; Long-term safety evaluation of suprachoroidal space following multiple suprachoroidal injection of triamcinolone acetonide (TA). Invest. Ophthalmol. Vis. Sci. 2016;57(12):762.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Suprachoroidal space (SCS) injection is an emerging technique to deliver drugs to the posterior segment. SCS drug administration is less invasive than intravitreal injection and more efficient than subtenon injection, bypassing clearance of the blood and lymphatic circulation a conjunctiva and episclera. However, long-term SCS changes following multiple injections are not well understood yet.

Methods : Six rabbit eyes were subjected to one to three consecutive bimonthly SCS injections of 50µL TA suspension. Prior to each injection, intraocular pressure (IOP), indirect ophthalmoscopy, and Ultrahigh Resolution Optical Coherence Tomography (UHR-OCT) were performed. Electroretinography (ERG) readings were collected prior to sacrifice. The area that encloses the space between the inner scleral wall and the RPE was measured in pixels on the cross sections of UHR-OCT at the injection site. Additional six rabbits had both eyes injected with 10% Acrylonitrile Butadiene Styrene (ABS in acetone and butanone 1:1) 20 minutes before sacrifice. The eye globe was corroded in 10% natrium hydroxide until the cast of the SCS was freestanding. The casting was imaged along with a ruler on the scleral side and holes smaller than 500µm were counted with a custom-written program. We hypothesize that the small holes on the cast may represent fluid channels between the choroid and the sclera.

Results : No clinical abnormalities were noted through the course of the study. The average IOP of the injected eyes versus their fellow eyes was 13.8±1.66 vs. 13.1±1.82 (p=0.002 paired t-test). The areas measured by imageJ on UHR-OCT cross sections showed no significant difference between the injected eyes and their contralateral eyes (at 8 weeks injected 1.01±0.09 vs. contralateral 0.94±0.18, p=0.24; at 16 weeks 0.74±0.2 vs. 0.87±0.17, p=0.02; at 24 weeks 1.08±0.14 vs. 1.18±0.19, p=0.35). There was also no difference in ERG b-wave amplitudes between the injected and the control eyes (flicker ERG, 59.7±20.1µV vs. 61.2±27µV, p=0.8). The small holes on the casting for the injected eye was 364.2±189.6 vs. 476.7±116.5 for the control eyes (p=0.035, paired t-test).

Conclusions : It seems suprachoroidal injections of TA at a volume of 50 µL were well tolerated in the rabbit eye, even with multiple injections. The suprachoroidal may experience subtle changes following the injections.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×